To further determine the underlying mechanism by which the EFNB2/EPHB4 axis contributes to CRC LM, we conducted a Gene Set Enrichment Analysis (GSEA) analysis based on EFNB2 expression in the CRC LM samples. This evidence concerns the gene EPHB4 and colorectal carcinoma.